CU Medical Systems, Inc. (KOSDAQ:115480)
587.00
+3.00 (0.51%)
At close: Jan 23, 2026
CU Medical Systems Revenue
CU Medical Systems had revenue of 11.27B KRW in the quarter ending September 30, 2025, with 54.89% growth. This brings the company's revenue in the last twelve months to 44.79B, up 18.05% year-over-year. In the year 2024, CU Medical Systems had annual revenue of 40.63B, down -2.81%.
Revenue (ttm)
44.79B
Revenue Growth
+18.05%
P/S Ratio
0.79
Revenue / Employee
392.85M
Employees
114
Market Cap
35.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.63B | -1.17B | -2.81% |
| Dec 31, 2023 | 41.80B | -5.15B | -10.98% |
| Dec 31, 2022 | 46.96B | 11.56B | 32.64% |
| Dec 31, 2021 | 35.40B | 7.08B | 25.01% |
| Dec 31, 2020 | 28.32B | 387.25M | 1.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 102.75B |
| DRGEM | 98.34B |
| JPI Healthcare | 52.79B |
| Hironic | 33.18B |
| Remed | 24.26B |
| Neofect | 20.50B |
| Bistos | 19.37B |
| MEKICS CO., | 11.70B |